Decitabine and Selinexor in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Clinical trial NCT02093403 · COMPLETED
Trial details
- NCT number
- NCT02093403
- Sponsor
- Bhavana Bhatnagar
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2016-11-26
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.